Injection for sleep apnea in people who can't use CPAP
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing clinical trials.
This study tests an injection for people with obstructive sleep apnea who cannot or will not use a CPAP machine. The treatment may help reduce sleep apnea severity and aid in weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a confirmed diagnosis of obstructive sleep apnea.
- You must be unwilling or unable to use a CPAP machine.
- Your BMI must be 28 or higher.
- You must not have used certain weight-loss or diabetes medications in the last 3 months.
- You must not have diabetes or a history of certain medical conditions (like pancreatic or thyroid issues).
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injected medication to see if it helps reduce the severity of obstructive sleep apnea in people with obesity. The trial will compare the drug to a placebo over several months to check safety and effectiveness.
This study tests a new injectable medicine (NNC0487-0111) to help people lose weight and improve obstructive sleep apnea (a breathing condition during sleep). You must already be using a CPAP machine (positive airway pressure device) for your sleep apnea.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
This study tests an injectable medication called HRS9531 for people with obesity and obstructive sleep apnea. The goal is to see if it can help reduce breathing pauses during sleep and promote weight loss.
This study tests a new injection (UBT251) to help people lose weight and improve weight-related health problems. You may qualify if you're overweight or obese and have tried diet and exercise for at least 3 months without much success.
This trial tests an injection called GZR18 to see if it helps people with obesity and obstructive sleep apnea who already use a CPAP machine. It may lead to weight loss and improve sleep apnea.
Hear when a new Obstructive Sleep Apnea, Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.